Search Results - Jennifer Mammen
- Showing 1 - 4 results of 4
-
1
-
2
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis by Laura C Cappelli, Clifton O Bingham, Patrick M Forde, Evan J Lipson, Megan Schollenberger, Ami A Shah, Julie Brahmer, Valsamo Anagnostou, Erika Darrah, Jennifer Mammen
Published in RMD Open (2022-11-01)Get full text
Article -
3
Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis by Elise F. Gray-Gaillard, Ami A. Shah, Clifton O. Bingham III, Jennifer H. Elisseeff, Joseph Murray, Julie Brahmer, Patrick Forde, Valsamo Anagnostou, Jennifer Mammen, Laura C. Cappelli
Published in Arthritis Research & Therapy (2025-04-01)Get full text
Article -
4
Accelerating Parkinson’s Disease drug development with federated learning approaches by Amit Khanna, Jamie Adams, Chrystalina Antoniades, Bastiaan R. Bloem, Camille Carroll, Jesse Cedarbaum, Joshua Cosman, David T. Dexter, Marissa F. Dockendorf, Jeremy Edgerton, Laura Gaetano, Erkuden Goikoetxea, Derek Hill, Fay Horak, Elena S. Izmailova, Tairmae Kangarloo, Dina Katabi, Catherine Kopil, Michael Lindemann, Jennifer Mammen, Kenneth Marek, Kevin McFarthing, Anat Mirelman, Martijn Muller, Gennaro Pagano, M. Judith Peterschmitt, Jie Ren, Lynn Rochester, Sakshi Sardar, Andrew Siderowf, Tanya Simuni, Diane Stephenson, Christine Swanson-Fischer, John A. Wagner, Graham B. Jones
Published in npj Parkinson's Disease (2024-11-01)Get full text
Article
